440 related articles for article (PubMed ID: 28788088)
1. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.
Ding SLS; Kumar S; Mok PL
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788088
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of Stem Cell-Based Therapy for Age-Related Retinal Degenerative Diseases.
Holan V; Hermankova B; Kossl J
Cell Transplant; 2017 Sep; 26(9):1538-1541. PubMed ID: 29113466
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.
Holan V; Palacka K; Hermankova B
Cells; 2021 Mar; 10(3):. PubMed ID: 33799995
[TBL] [Abstract][Full Text] [Related]
4. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
Liang X; Ding Y; Zhang Y; Tse HF; Lian Q
Cell Transplant; 2014; 23(9):1045-59. PubMed ID: 23676629
[TBL] [Abstract][Full Text] [Related]
5. A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications.
Cislo-Pakuluk A; Marycz K
Stem Cell Rev Rep; 2017 Oct; 13(5):598-602. PubMed ID: 28643176
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
Wang J; Liao L; Tan J
Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
[TBL] [Abstract][Full Text] [Related]
7. Extracardiac-Lodged Mesenchymal Stromal Cells Propel an Inflammatory Response Against Myocardial Infarction via Paracrine Effects.
Peng Y; Pan W; Ou Y; Xu W; Kaelber S; Borlongan CV; Sun M; Yu G
Cell Transplant; 2016; 25(5):929-35. PubMed ID: 26498018
[TBL] [Abstract][Full Text] [Related]
8. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.
Holan V; Trosan P; Cejka C; Javorkova E; Zajicova A; Hermankova B; Chudickova M; Cejkova J
Stem Cells Transl Med; 2015 Sep; 4(9):1052-63. PubMed ID: 26185258
[TBL] [Abstract][Full Text] [Related]
10. Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?
Ezquer F; Ezquer M; Arango-Rodriguez M; Conget P
Acta Ophthalmol; 2014 Mar; 92(2):e86-95. PubMed ID: 23773776
[TBL] [Abstract][Full Text] [Related]
11. Empowering Mesenchymal Stem Cells for Ocular Degenerative Disorders.
Ding SSL; Subbiah SK; Khan MSA; Farhana A; Mok PL
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974904
[TBL] [Abstract][Full Text] [Related]
12. Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.
Li F; Whyte N; Niyibizi C
Biochem Biophys Res Commun; 2012 Oct; 426(4):475-9. PubMed ID: 22960177
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect.
Kusuma GD; Carthew J; Lim R; Frith JE
Stem Cells Dev; 2017 May; 26(9):617-631. PubMed ID: 28186467
[TBL] [Abstract][Full Text] [Related]
14. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
[TBL] [Abstract][Full Text] [Related]
15. Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts.
Yao Y; Huang J; Geng Y; Qian H; Wang F; Liu X; Shang M; Nie S; Liu N; Du X; Dong J; Ma C
PLoS One; 2015; 10(6):e0129164. PubMed ID: 26043119
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives.
Hu H; Zou C
Curr Stem Cell Res Ther; 2017; 12(3):183-187. PubMed ID: 27781940
[TBL] [Abstract][Full Text] [Related]
17. Retina tissue engineering by conjunctiva mesenchymal stem cells encapsulated in fibrin gel: Hypotheses on novel approach to retinal diseases treatment.
Soleimannejad M; Ebrahimi-Barough S; Nadri S; Riazi-Esfahani M; Soleimani M; Tavangar SM; Ai J
Med Hypotheses; 2017 Apr; 101():75-77. PubMed ID: 28351499
[TBL] [Abstract][Full Text] [Related]
18. Overview of retinal differentiation potential of mesenchymal stem cells: A promising approach for retinal cell therapy.
Salehi H; Amirpour N; Razavi S; Esfandiari E; Zavar R
Ann Anat; 2017 Mar; 210():52-63. PubMed ID: 27986614
[TBL] [Abstract][Full Text] [Related]
19. Cytotherapy using stromal cells: Current and advance multi-treatment approaches.
Shende P; Gupta H; Gaud RS
Biomed Pharmacother; 2018 Jan; 97():38-44. PubMed ID: 29080456
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell insights: prospects in cardiovascular therapy.
Chou SH; Lin SZ; Kuo WW; Pai P; Lin JY; Lai CH; Kuo CH; Lin KH; Tsai FJ; Huang CY
Cell Transplant; 2014; 23(4-5):513-29. PubMed ID: 24816448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
